Management of Patients After CAR-T Therapy: Adverse Reactions and Follow Up
By: Brigett Brandjes, PA-C, MMSc
Novel Platforms to Assess the Cancer Continuom Using Liquid Biopsy
By: Christian Rolfo, MD, PhD, MBA, Dr.h.c.
Novel Platforms to Assess the Cancer Continuom Using Liquid Biopsy
By: Christian Rolfo, MD, PhD, MBA, Dr.h.c.
Convergence of Liquid Biopsy and Precision Oncology in the Management of NSCLC
By: David Gandara, MD & Jonathan W. Riess, MD, MS
Convergence of Liquid Biopsy and Precision Oncology in the Management of NSCLC
By: David Gandara, MD & Jonathan W. Riess, MD, MS
Management of Oligometastatic Disease in the Liver By Interventional Radiology: Novel Advances
By: Curtis L. Anderson, MD, PhD
Time to Transplant – An important factor in selection of liver directed therapy
By: Jafar Golzarian, MD
Irreversible Electroporation in Hepatocellular Carcinomas Adjacent to Critical Anatomical Structures, a Single Centre Experience
By: Nuran Seneviratne, MA, MBBS
